Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Hanekom

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Infectious Diseases|November 2, 2013
Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infantsF Lutwama, B M Kagina, A Wajja, et al.
Mucosal Immunology|August 24, 2017
Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in miceS P Parihar, M Ozturk, M J Marakalala, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 15, 2010
Impact of age and sex on mycobacterial immunity in an area of high tuberculosis incidenceC J Gallant, A Cobat, L Simkin, et al.
Mucosal Immunology|January 19, 2018
Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in miceS P Parihar, M Ozturk, M J Marakalala, et al.
IJTLD Open|April 17, 2026
Interferon-gamma release assay positivity in populations at high risk of TB infectionA F Dagnew, L L Han, A Cinar, et al.
Vaccine|May 5, 2015
A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infantsM Tameris, D A Hokey, V Nduba, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Infectious Diseases|November 2, 2013
Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infantsF Lutwama, B M Kagina, A Wajja, et al.
Mucosal Immunology|August 24, 2017
Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in miceS P Parihar, M Ozturk, M J Marakalala, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 15, 2010
Impact of age and sex on mycobacterial immunity in an area of high tuberculosis incidenceC J Gallant, A Cobat, L Simkin, et al.
Mucosal Immunology|January 19, 2018
Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in miceS P Parihar, M Ozturk, M J Marakalala, et al.
IJTLD Open|April 17, 2026
Interferon-gamma release assay positivity in populations at high risk of TB infectionA F Dagnew, L L Han, A Cinar, et al.
Vaccine|May 5, 2015
A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infantsM Tameris, D A Hokey, V Nduba, et al.
Pageof 3